EDITOR-IN-CHIEF James K. Drennen, III, Duquesne University, Pittsburgh, PA, USA CO-EDITOR Stephen Scypinski, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA ASSOCIATE EDITORS Douglas Both, Bristol-Myers Squibb, New Brunswick, NJ, USA Wilson Meng, Duquesne University, Pittsburgh, PA, USA EDITORIAL ADVISORY BOARD Ira Buckner, Duquesne University, Pittsburgh, PA, USA Emanuel Diliberto, Campbell University, Builes Creek, NC, USA Tom Fearn, University College London, London, UK Mauricio Futran, Johnson & Johnson, New Brunswick, NJ, USA Stefano Giovagnoli, University of Perugia, Perugia, Italy Brijesh Dave, Amerigen Pharmaceuticals, Lyndhurst, NJ, USA Robert Guttendorf, Aclairo Pharmaceutical Development Group, Vienna, VA, USA Yukio Hiyama, National Institute of Health Sciences, Tokyo, Japan Kristiina Jarvinen, University of Kuopio, Kuopio, Finland Robert Lipper, Back Cove Pharma, LLC, Waldoboro, MA, USA James Litster, University of Sheffield, Sheffield, UK Robert Lodder, University of Kentucky, Lexington, KY, USA Gary McGeorge, Bristol-Myers Squibb, New Brunswick, NJ, USA Mike Morris, Health Products Regulatory Authority, Dublin, Ireland June Mullaney Mader, GoForward LLC, Raleigh, NC, USA Eric Munson, University of Kentucky, Lexington, KY, USA Fernando Muzzio, Rutgers University, Piscataway, NJ, USA Stuart Porter, Ashland Specialty Ingerdients, Wilmington, DE, USA Rex Reklaitis, Purdue University, West Lafayette, IN, USA Paul Sharratt, Institute for Chemical Engineering and Sciences (ICES), Jurong Island, Singapore Steven Short, Merck & Co., Inc., Summit, NJ, USA Nicholas Snow, Seton Hall University, South Orange, NJ, USA Qiang Zheng, Peking University, Beijing, China Sameer Talwar, GlaxoSmithKline, Collegeville, PA, USA
|
京公网安备 11010802027423号